|
Market Closed -
Swiss Exchange
12:30:07 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 73.40 CHF | +1.66% |
|
+8.74% | +34.19% |
| 10-27 | Basilea Pharmaceutica Lifts FY26 Guidance | MT |
| 10-27 | Basilea raises full-year guidance 2026 and financial target for "Agenda 2030" and provides updates on late-stage clinical programs | DJ |
Chart calendar Basilea Pharmaceutica AG
Upcoming events on Basilea Pharmaceutica AG
| Today | Analyst/Investor Day | 09:00 |
| 2026-11-03 | Information meeting |
Past events on Basilea Pharmaceutica AG
| 2026-10-06 | Information meeting | |
| 2026-08-18 | Earnings presentation | 10:00 |
| 2026-08-18 | Earnings release - Q2 2026 | |
| 2026-04-15 | Annual General Meeting | 08:00 |
| 2026-04-07 | Information meeting | |
| 2026-03-30 | Information meeting | |
| 2026-02-17 | Earnings presentation | 10:00 |
| 2026-02-16 | Earnings release - Annual 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 158 156 0.97% | 209 199 4.89% | 232 225 3.23% | 273 | 286 | 210 |
|
EBITDA Million CHF | Released Forecast Spread | 20,8 15,8 31.62% | 62,9 42,2 49.02% | 53,4 52,6 1.43% | 77,3 | 57,6 | 13,9 |
|
EBIT Million CHF | Released Forecast Spread | 19,2 14,8 29.78% | 61,2 39,7 54.25% | 51,5 50,7 1.63% | 94,6 | 58,1 | 11,5 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 10,5 5,36 95.31% | 60,3 38,2 57.78% | 45,9 45,2 1.61% | 73,2 | 58,4 | 12,6 |
|
Net income Million CHF | Released Forecast Spread | 10,5 5,35 96.21% | 77,6 46,8 65.98% | 40,2 39,3 2.35% | 68,1 | 57,8 | 6,41 |
|
EPS CHF | Released Forecast Spread | 0,86 0,43 101.28% | 5,83 4,02 45.11% | 3,14 3,03 3.68% | 4,92 | 4,17 | 0,81 |
| Announcement Date | 13/02/24 | 18/02/25 | 17/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 S2 | 2025 S1 | 2025 Q4 | 2025 S2 | 2026 S1 | 2026 S2 | 2027 S1 | 2027 S2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 132 124 7.03% | 104 98,7 5.42% | 120 | 128 121 6.59% | 119 119 -0.04% | 154 | 138 | 153 |
|
EBITDA Million CHF | Released Forecast Spread | 52,8 26,8 97.45% | 25,0 26,6 -6.09% | 24,3 | 28,4 24,0 18.17% | 32,6 53,0 -38.53% | 57,0 | ||
|
EBIT Million CHF | Released Forecast Spread | 51,9 30,3 71.38% | 24,0 24,4 -1.67% | 24,3 | 27,5 25,0 9.72% | 31,6 36,4 -13.07% | 52,1 | ||
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | 53,0 29,9 77.14% | 19,3 25,5 -24.29% | 24,6 | 26,6 25,5 3.99% | 32,1 53,0 -39.43% | 40,8 | ||
|
Net income Million CHF | Released Forecast Spread | 56,9 31,0 83.61% | 15,8 23,8 -33.55% | 21,4 | 24,4 21,1 15.36% | 27,9 46,0 -39.35% | 40,2 | ||
|
EPS CHF | Released Forecast Spread | 4,22 2,48 70.36% | 1,26 1,89 -33.37% | 1,54 | 1,88 1,64 14.98% | 2,13 3,34 -36.23% | 3,28 | 2,47 | 3,45 |
| Announcement Date | 18/02/25 | 19/08/25 | - | 17/02/26 | 18/08/26 | - | - | - |
| 2026-10-28 | Board of Directors Meeting | ||
| 2026-10-28 | Board of Directors Meeting | ||
| 2026-10-28 | Earnings presentation | 22:00 | |
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings presentation | 08:30 | |
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings release - Q3 2026 | ||
| 2026-10-29 | Earnings presentation | 08:00 |
Past sector events for Basilea Pharmaceutica AG
| Today | Earnings presentation | 08:00 | |
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings presentation | 08:00 | |
| Today | Earnings release - Q2 2027 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| 2026-10-27 | Earnings presentation | 09:00 | |
| 2026-10-27 | Earnings release - Q3 2026 | ||
| 2026-10-27 | Earnings release - Q3 2026 | ||
| Today | Board of Directors Meeting |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
- Calendar Basilea Pharmaceutica AG
Select your edition
All financial news and data tailored to specific country editions
















